:HCC线

Dizhi Jiang1, Xinyue Ma1, Xun Zhang1

  • 1Department of Radiation Oncology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.

PubMed
概括

肝细胞癌 (HCC) 免疫疗法由于新的技术和独特的肝脏免疫微环境而显得有前途. 像CRISPR这样的进步为HCC提供了新的诊断和治疗点,改善了患者的治疗结果.